About this trial
The purpose of this clinical trial is to determine how the supplement oregano affects how the body metabolizes pharmaceutical drugs.
Eligibility criteria
Qualifiers
Between 18-64 years old and healthy
Not taking any medications (prescription and non-prescription) or dietary/herbal supplements that can interfere with study drug pharmacokinetics
Willing to abstain from consuming dietary/herbal supplements and citrus juices for several weeks
Willing to abstain from cannabis/marijuana, hemp, and THC- and CBD-containing products for several weeks
Disqualifiers
Under 18 or over 64 years old
Taking medications or dietary/herbal supplements that can interfere with study drug pharmacokinetics
Have a major illness
Taking medication/supplements for a mineral deficiency
Trial design
Treatments tested in this trial
- Oregano
- Drug cocktail
Treatment groups
Sponsors and collaborators
Washington State University
Lead sponsor
Office of Dietary Supplements (ODS)
Collaborator
National Center for Complementary and Integrative Health (NCCIH)
Collaborator